SCHEMBL9764839

SCHEMBL9764839

CC(=O)N(O)CCc1ccc2c(c1)oc1ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 4/20 0.44
MMP12 P39900 1/20 0.44
MMP13 P45452 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MME P08473 1/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP2D6 P10635 1/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
CYP2C9 P11712 1/20 0.42
GAA P10253 1/20 0.42
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
TTR P02766 1/20 0.40
AHR P35869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764922 0.88 ALOX5 (0.49) ECE1MMP12MMP13MEN1KMT2A
SCHEMBL9764895 0.86 NPC1 (0.47) ECE1MMP12MMP13MEN1KMT2A
SCHEMBL9764821 0.84 KMT2A (0.45) ECE1MMP12MMP13MEN1KMT2A
SCHEMBL10561801 0.80 CYP1A2 (0.51) ECE1MMP12MMP13MEN1KMT2A
SCHEMBL10593682 0.80 CYP1A2 (0.43) ECE1MMP12MMP13MEN1KMT2A
SCHEMBL9764809 0.78 PLA2G10 (0.40) ECE1MMP12MMP13MEN1KMT2A
SCHEMBL9764824 0.76 NPC1 (0.43) ECE1MMP12MMP13MEN1KMT2A
SCHEMBL19768725 0.76 CYP1A2 (0.57) ECE1MMP12MMP13MEN1KMT2A
Ammonia Solution, Strong SCHEMBL9764837 0.75 ALDH1A1 (0.39) CYP1A2NPC1RAB9ASMN1; SMN2GAA
SCHEMBL21510705 0.75 CYP1A2 (0.53) ECE1MMP12MMP13MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0422079-A4 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE 1991-08-21 EP disclosed
EP-0422079-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1991-04-17 EP disclosed
WO-1989012636-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1989-12-28 WO disclosed